A dose audit is the routine proof that the radiation dose you validated years ago still sterilises the product you are making today. ISO 11137-3 is the part of the radiation family that governs how dosimetry supports that proof; ISO 11137-2 is the part that defines the audit and, more importantly, what a given number of positives actually permits a supplier to do next. This guide separates the measurement question from the decision question, sets out the response ladder triggered by an audit failure, and lists the records a Canadian buyer can demand when a contract sterilizer changes site, dose or dose-setting method.
Quick Summary: A dose audit combines bioburden testing with a sterility test at the verification dose, and it is normally run once every three months. The result is not pass or fail — ISO 11137-2 sets bands of positives, and each band allows a different action, from "no change" through immediate dose augmentation to full dose re-establishment with no augmentation permitted at all. The record that matters afterwards is the one that ties dose, dosimeter calibration, sterilization cycle and production batch together.
Facilities that keep dose records next to their routine monitoring usually keep the physical monitoring in the same cabinet, and a spore-check you can read and log in-house is the practical starting point:
24-hour self-contained biological indicators — 25-pack are read on the bench and filed against the cycle they challenged.

What does ISO 11137-3:2017 actually cover?
The scope is narrow and worth quoting exactly, because it is routinely stretched past what the document says. ISO 11137-3:2017 "gives guidance on meeting the requirements in ISO 11137-1 and ISO 11137-2 and in ISO/TS 13004 relating to dosimetry and its use in development, validation and routine control of a radiation sterilization process" (EVS catalogue record).
Three consequences follow from that sentence:
- It is guidance, not requirement. The word "requirements" belongs to Part 1 and Part 2. A supplier cannot be "non-compliant with ISO 11137-3" in the way it can be non-compliant with Part 1; the finding sits against the requirement the guidance was supporting.
- It is scoped to dosimetry. Dose measurement, dosimeter selection and calibration, placement, and the use of dosimetric data. It does not define how many positives are acceptable in a dose audit — that decision logic lives in the dose-setting standard.
- It is a companion to ISO/TS 13004 as well. If a product's dose was substantiated under the VDmaxSD approach rather than set under the classical methods, the dosimetric guidance still applies.
For a buyer, the practical translation is this: the dosimetry evidence proves the dose you paid for was delivered; the audit evidence proves that delivered dose still achieves the required sterility assurance level. You need both, and they come from different records.
Which editions are current in 2026?
The radiation family has moved recently, and the part that moved is the one that carries the requirements. The table below reflects the catalogue entries of a national standards body member at the time of writing, not a supplier's certificate.
| Standard | Edition in the catalogue | Valid from | What it governs |
|---|---|---|---|
| ISO 11137-1 | 2025 | 02.04.2025 | Requirements for development, validation and routine control of a radiation sterilization process |
| ISO 11137-2 | 2013 (plus Amd 1:2022) | 21.05.2013 / 13.06.2022 | Establishing the sterilization dose, and the sterilization dose audit methods |
| ISO 11137-3 | 2017 | 26.06.2017 | Guidance on dosimetric aspects of development, validation and routine control |
| ISO/TS 13004 | 2013 | — | Substantiation of a selected dose (VDmaxSD), plus a dose audit method for that route |
| ISO 11737-1 | 2018 | — | Enumeration and microbial characterisation of bioburden |
The 2025 edition of Part 1 replaced the 2006 edition together with its two amendments (Amd 1:2013 and Amd 2:2018); the catalogue record lists all three under a single superseded entry (ISO 11137-1:2025, ISO 11137-1:2006). Part 2 has not been replaced — the 2013 edition with its 2022 amendment is still the current text (ISO 11137-2:2013) — and Part 3 was not revised alongside Part 1; the 2017 edition remains listed as current, with no successor edition in the catalogue.
That combination creates a cross-reference problem you can see in real audit reports. Part 2:2013 was written against the 2006 edition of Part 1, so the audit method is conventionally described in reports as being carried out "in accordance with ISO 11137-1, Clause 12". If the report cites a clause in a withdrawn edition, the observation is not automatically wrong — the audit method itself did not change — but the requirement reference no longer points at the document in force. Ask which edition each record cites, and treat a 2006 reference in a 2026 report as a documentation finding rather than a technical one.
The scope of the current Part 1 also tightens one boundary that matters for combination products: it covers irradiators using cobalt-60 or caesium-137, an electron beam, or an X-ray beam, and it is "not applicable to processes for inactivating viruses or the causative agents of spongiform encephalopathies" (scope, ISO 11137-1:2025). Radiation doses validated for sterility do not automatically satisfy viral or prion inactivation claims.
How often is a dose audit run, and how many units does it test?
A dose audit is not a single test. It is a paired exercise: bioburden enumeration from the production family, followed by a sterility test of units exposed to the verification dose (STERIS AST, Method 1 quarterly dose audits). Both halves matter, because the two together are what tell you whether the bioburden population changed or whether its radiation resistance changed — and those two findings lead to different actions.
The typical audit schedule is once every three months (STERIS AST, VDmax25 quarterly dose audits). Reducing that frequency is possible under the routes described in the Part 1 family, but it is a justified reduction with a documented basis, not a scheduling preference — and a supplier who has moved to annual audits without showing you the justification has given you a question to ask rather than an answer.
Two sample-logic details are frequently missed in procurement review:
- A confirmatory test is a second sample set, not a retest of the same units. When the VDmax25 audit returns two positives, the confirmatory test repeats the sterility test at the same verification dose and requires ten additional samples, after which the result is read across twenty units rather than ten.
- Product families, not SKUs, are the audit unit. Part 2 defines product families for both dose establishment and dose audit, which is why one audit report can cover a whole range of sizes or pack configurations — and why a new size added to a family needs a documented family rationale, not a new audit by default.
What does each audit result permit? The four failure bands
This is the part of the standard that gets flattened into a single word in supplier correspondence. The decision logic is banded, and two of the bands explicitly remove the option to retest.
| Audit result | What it means | What is permitted | What is not |
|---|---|---|---|
| Method 1: 0–2 positives | Sterilization dose selected at validation still holds | No action; continue the audit schedule | — |
| Method 1: 3–4 positives | Dose is in question | Immediate augmentation to the greater of two recalculated doses; a retest at the original verification dose may be run to test a return | Continuing at the current dose |
| Method 1: 5–6 positives | Original dose is not sufficient | If bioburden rose, augment immediately; if bioburden did not rise, re-establish the dose | Retesting, unless there is evidence of a compromised procedure or an improperly delivered dose |
| Method 1: 7 or more positives | Radiation resistance has likely changed | Re-establish the sterilization dose | Augmentation and retesting |
| VDmax25: 0–1 positives | 25 kGy confirmed | No action; continue the schedule | — |
| VDmax25: 2 positives | Not yet a failure | Confirmatory test with 10 additional samples at the same verification dose | Declaring the dose confirmed before the confirmatory result |
| VDmax25: confirmatory 1–4 positives | 25 kGy not confirmed | Augment to 25 kGy plus the dose augmentation value; the augmented dose is interim only | Treating the augmented dose as a new validated dose-setting method |
| VDmax25: confirmatory 5 or more | Equivalent to seven or more positives | Select an alternative dose-setting method | Any augmentation; repeating the audit experiment without evidence of an incorrect procedure or a delivered dose below 90% of the verification dose |
Two disclosures belong with that table. First, the decision rules above are as published in widely used industry technical guidance written against the 2006 editions of Part 1 and Part 2, and they reference that edition's dose tables. The method carried into the 2013 edition and its 2022 amendment, but table numbering and any recalculated factors must be confirmed against the edition actually in force at the sterilizer — a quotation from a 2006 table in a current report is a traceability gap. Second, "augmentation" and "re-establishment" are not synonyms and they carry different validation burdens. Augmentation is an interim increase while an alternative method is selected; re-establishment is a new dose-setting exercise with its own bioburden work and its own report.
What triggers re-qualification rather than another audit?
A failed audit is only one of the triggers. In practice the trigger set is broader, and it is governed by change control rather than by the audit itself.
- A change of irradiator site or source. Dose mapping, conveyor speed and product orientation are facility-specific. A new site means new dose mapping and a fresh validation package, even for an identical product and an identical nominal dose.
- A change of modality. Cobalt, electron beam and X-ray deposit dose differently through a product's depth. A transfer between them is a process change, not a logistics change.
- A change in dose-setting route. Moving from a classical method to VDmax substantiation changes the audit's acceptance logic, so the audit history under the old route cannot be carried forward unexamined.
- A bioburden shift without a positive result. A rising bioburden trend with a passing audit is an early warning; the standards route that through the quality system as a change to be assessed, not as a curiosity.
- A packaging or configuration change that alters density. Sterile barrier validation and dose distribution are coupled through product density and load pattern.
Re-validation after a change is a quality-system obligation as much as a technical one: the process-validation requirements expect revalidation where changes to the process occur, and the sterilization-specific clause of the medical device quality standard is the one buyers usually quote when they ask for it.

What must the record show?
The following set is what a competent auditor will ask to see, and what a buyer should be able to obtain without a negotiation. It is built from the dosimetric guidance in Part 3, the batch-record requirement that applies to sterile devices, and the distribution-record obligation Canadian law places on importers and distributors.
| Record | What it must show | Issued by |
|---|---|---|
| Dose audit report, per quarter | Product family, audit date, bioburden count, sterility test result in positives, verification dose delivered, the band applied and the resulting decision | Contract sterilizer with the manufacturer |
| Dosimetry record | Dosimeter type, calibration certificate and traceability chain, measurement uncertainty, dose measured against dose specified | Contract sterilizer |
| Sterilization batch record | Process parameters for each sterilization batch, traceable to each production batch of devices — the requirement is stated in ISO 13485 clause 7.5.5 | Manufacturer |
| Deviation and investigation file | Why a band was entered, what investigation followed, retest justification if any, disposition of affected product, corrective action | Manufacturer |
| Change record | Any site, modality, dose or family change, with the re-validation that followed and its approval | Manufacturer |
| Certificate of irradiation | Dose range delivered, lot or batch covered, date, facility | Contract sterilizer |
| Distribution record | Enough information to permit complete and rapid recall of the device | Importer and distributor, per the Medical Devices Regulations |
That last row is not a quality nicety. Under the Canadian Medical Devices Regulations, the manufacturer, importer and distributor of a medical device must each maintain a distribution record, and the record must contain sufficient information to permit the complete and rapid recall of the device (section 52, section 53). If a dose audit failure leads to quarantine, the ability to name the affected batches and the customers who received them is the difference between a recall and a crisis. Incident reporting follows the same logic: the manufacturer and the importer each owe a preliminary and a final report, due within 10 days where the incident led to death or serious deterioration and within 30 days where it did not but could (section 59, section 60).
What should a Canadian buyer request when a supplier changes?
Ask for the package below in writing, and set a date for it. The list assumes an existing supplier relationship where historical audits exist; for a new supplier, expand the audit history request to the full validation life.
- The current validation report for the specific site, with dose mapping data and the load configuration used.
- The last four quarterly audit reports, including the bioburden trend rather than only the sterility result.
- A statement of conformity naming the edition of Part 1 and Part 2 applied — 2025 and 2013/Amd 1:2022 respectively, or a documented justification for an earlier edition.
- Dosimeter calibration certificates with the traceability chain, and the uncertainty statement used in the dose decision.
- The product family rationale if your SKUs are being added to an existing family.
- The change notice that triggered the request, with the re-validation plan and its approval date.
- Packaging re-validation where the change alters density or load pattern.
- A batch-to-dose linkage sample, not a description of one: pick one recent production batch and trace it to its sterilization cycle and certificate.
Two internal references are useful when arguing the package internally rather than with the supplier: how a radiation sterilization dose is set under ISO 11137-2 explains the method behind the audit numbers, and the differences in which ISO 11137-1 edition applies in Canada versus the United States explains why a supplier's US-facing certificate may cite an edition that is not current. For the wider document set around a sterilizer rather than a sterilizer's process, the IQ/OQ/PQ document breakdown is the parallel checklist.
Buyers who need the physical side of the same discipline — pouches, rolls and indicators that carry cycle records a clinic can actually file — can start from the sterilization monitoring collection, and the 76 mm × 50 m heat-seal sterilization roll is the format most often paired with a batch-level log because the cut length is written into the record, and institutional purchasers can use the wholesale and institutional supply account route for multi-site orders. If the question is how to document the audit trail at clinic level rather than at sterilizer level, the sterilization compliance hub is the entry point, and the free compliance log centre produces the log sheets that sit in front of the dose certificate in a survey. Where a distributor has to answer a provincial inspector on documentation that arrives from a contract sterilizer, compliance consultation is the escalation route. Reselling? become a distributor.
Related reading
- ISO 11137-2: How a Radiation Sterilization Dose Is Set
- What Does ISO 11137-1 Actually Require? Which Edition Applies in Canada vs the US
- IQ/OQ/PQ Validation Documents for Sterilizers: What Must Be Inside
Frequently Asked Questions
Does a failed dose audit mean the product is non-sterile?
Not by itself. A dose audit failure is a statistical signal that the validated dose may no longer achieve the required sterility assurance level for the current bioburden. The affected batches are typically placed on hold while the investigation runs, and the decision on disposition follows the documented investigation rather than the audit result alone.
How many positives are allowed in a dose audit?
It depends on the method. Under classical dose setting, two or fewer positives means the dose still holds; three to four triggers immediate augmentation; five to six removes retesting in most circumstances; seven or more requires the dose to be re-established. Under VDmax25, zero or one confirms 25 kGy and two requires a confirmatory test with ten additional samples.
Is the audit frequency quarterly in every case?
Once every three months is the typical schedule. Reduction is possible where a documented justification supports it, so the correct question for a supplier is not whether annual audits are allowed but which basis and which record support the reduced frequency.
Does ISO 11137-3 set the acceptance criteria for a dose audit?
No. Part 3 is guidance on dosimetric aspects of development, validation and routine control. The acceptance logic for audit results sits with the dose-setting standard, which is Part 2 for classical methods and ISO/TS 13004 for VDmaxSD substantiation.
Which ISO 11137-1 edition should a 2026 certificate cite?
The 2025 edition, which replaced the 2006 edition and its amendments in April 2025. A report citing the 2006 edition is not necessarily technically wrong, because the audit method in Part 2 did not change, but the requirement reference no longer points at the document in force and should be corrected at the next document review.
What is the difference between dose augmentation and re-establishing the dose?
Augmentation is an interim increase applied while an alternative dose-setting method is selected, and it is permitted only in defined bands. Re-establishment is a new dose-setting exercise with fresh bioburden data and a new report, and it is mandatory where the audit shows a change in radiation resistance rather than only an increase in numbers.
Can a buyer see the audit data, or only a passing certificate?
A buyer can contract for audit reports rather than certificates. The certificate of irradiation proves dose was delivered to a lot; the audit report is what shows the dose still works. Quality agreements that name the four most recent quarterly reports as deliverables convert a verbal assurance into a document you can file.
CliniEco Medical distributes medical consumables under Health Canada MDEL #35334, and the monitoring products referenced here are supplied for facilities that maintain their own cycle records and dose documentation.